- $0.49m
- $3.45m
- $31.70m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.09 | ||
| Price to Tang. Book | 0.09 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -259.28% | ||
| Return on Equity | -199.6% | ||
| Operating Margin | -92.63% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 23.35 | 33.2 | 41.66 | 34.63 | 31.7 | 35.7 | 42.3 | -1.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to dissolve tissue and bacteria using minimal or no instrumentation. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
Directors
- Dan Even CHM
- Bjarne Bergheim PRE
- Michael Watts CFO
- Andrew Kirkpatrick COO
- Roy Chen OTH
- Carolyn Beaver DRC (63)
- Karen McGinnis DRC (54)
- Sadie Stern DRC (46)
- Raj Pudipeddi IND (48)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 9th, 2006
- Public Since
- October 29th, 2021
- No. of Shareholders
- 130
- No. of Employees
- 131
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 427,401
- Address
- 26061 Merit Circle, Suite 102, LAGUNA HILLS, 92653
- Web
- https://sonendo.com/
- Phone
- +1 9497663636
- Contact
- Greg Chodaczek
- Auditors
- BDO USA, P.C.
Upcoming Events for SONX
Sonendo Inc Annual Shareholders Meeting
Q2 2025 Sonendo Inc Earnings Release
Similar to SONX
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the Sonendo share price?
As of Today at 23:20 UTC, shares in Sonendo are trading at $1.14. This share price information is delayed by 15 minutes.
How has the Sonendo share price performed this year?
Shares in Sonendo last closed at $1.14 and the price had moved by -93.71% over the past 365 days. In terms of relative price strength the Sonendo share price has underperformed the S&P500 Index by -94.12% over the past year.
What are the analyst and broker recommendations for Sonendo?
The overall consensus recommendation for Sonendo is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sonendo dividend yield?
Sonendo does not currently pay a dividend.
Does Sonendo pay a dividend?
Sonendo does not currently pay a dividend.
When does Sonendo next pay dividends?
Sonendo does not currently pay a dividend.
How do I buy Sonendo shares?
To buy shares in Sonendo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sonendo?
As of the previous close price of $1.14, shares in Sonendo had a market capitalisation of $0.49m.
Where are Sonendo shares listed?
Here are the trading details for Sonendo:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SONX
What kind of share is Sonendo?
Based on an overall assessment of its quality, value and momentum Sonendo is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sonendo share price forecast for 2025?
The analyst consensus target price for shares in Sonendo is $30.00. That is 2531.58% above the last closing price of $1.14.
Analysts covering Sonendo currently have a consensus Earnings Per Share (EPS) forecast of -$53.51 for the next financial year.
Find out moreWhat is the trend in the Sonendo share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sonendo. Over the past six months, its share price has underperformed the S&P500 Index by -88.2%.
As of the last closing price of $1.14, shares in Sonendo were trading -87.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sonendo PE Ratio?
The Sonendo PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sonendo?
Sonendo's management team is headed by:
- Dan Even - CHM
- Bjarne Bergheim - PRE
- Michael Watts - CFO
- Andrew Kirkpatrick - COO
- Roy Chen - OTH
- Carolyn Beaver - DRC
- Karen McGinnis - DRC
- Sadie Stern - DRC
- Raj Pudipeddi - IND